Wednesday, 30 April 2014

Rituximab May Help in RA Lung Disease

LIVERPOOL (MedPage Today) -- Patients with rheumatoid arthritis who have interstitial lung disease (ILD) appeared to have a survival advantage if treated with rituximab rather than with a tumor necrosis factor (TNF) inhibitor, a researcher said here. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment